Education
About Us
Working with TipRanks
Follow Us
NervGen Pharma (TSE:NGEN)
:NGEN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -83.80K | C$ -145.00K | C$ -115.11K | C$ -42.63K | C$ -39.65K |
| Operating Income | C$ -24.93M | C$ -17.78M | C$ -22.82M | C$ -12.87M | C$ -11.19M |
| EBITDA | C$ -23.92M | C$ -17.72M | C$ -20.09M | C$ -12.77M | C$ -11.16M |
| Net Income | C$ -24.01M | C$ -22.38M | C$ -18.11M | C$ -12.64M | C$ -11.18M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 17.36M | C$ 11.66M | C$ 22.45M | C$ 16.93M | C$ 5.60M |
| Total Assets | C$ 19.49M | C$ 13.24M | C$ 23.88M | C$ 17.90M | C$ 6.68M |
| Total Debt | C$ 105.60K | C$ 197.19K | C$ 283.45K | C$ 0.00 | C$ 0.00 |
| Net Debt | C$ -17.16M | C$ -11.46M | C$ -22.17M | C$ -16.93M | C$ -5.60M |
| Total Liabilities | C$ 16.91M | C$ 15.25M | C$ 10.41M | C$ 1.08M | C$ 755.07K |
| Stockholders' Equity | C$ 2.58M | C$ -2.01M | C$ 13.46M | C$ 16.82M | C$ 5.92M |
| Cash Flow | |||||
| Free Cash Flow | C$ -16.84M | C$ -11.44M | C$ -17.81M | C$ -8.31M | C$ -6.31M |
| Operating Cash Flow | C$ -16.84M | C$ -11.30M | C$ -17.78M | C$ -8.27M | C$ -6.31M |
| Investing Cash Flow | C$ 58.87K | C$ -138.85K | C$ -21.11K | C$ -45.09K | C$ -3.42K |
| Financing Cash Flow | C$ 22.70M | C$ 766.28K | C$ 22.64M | C$ 19.61M | C$ 7.85M |
NervGen Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.